[1]Li JJ, Xie D. RACK1, a versatile hub in cancer[J]. Oncogene,2015,34(15):1890-1898.
[2]Gandin V, Senft D, Topisirovic I, et al. RACK1 function in cell motility and protein synthesis[J]. Genes Cancer, 2013,4(9-10):369-377.
[3]Myklebust LM, Akslen LA, Varhaug JE, et al. Receptor for activated protein C kinase 1 (RACK1) is overexpressed in papillary thyroid carcinoma[J]. Thyroid,2011,21(11):1217-1225.
[4]Lin Y, Cui M, Teng H, et al. Silencing the receptor of activated C-kinase 1 (RACK1) suppresses tumorigenicity in epithelial ovarian cancer in vitro and in vivo[J]. Int J Oncol,2014,44(4):1252-1258.
[5]Jin S, Mu Y, Wang X, et al. Overexpressed RACK1 is positively correlated with malignant degree of human colorectal carcinoma[J]. Mol Biol Rep,2014,41(5):3393-3399.
[6]Li X, Xiao Y, Fan S, et al. RACK1 overexpression associates with pancreatic ductal adenocarcinoma growth and poor prognosis[J]. Exp Mol Pathol,2016,101(2):176-186.
[7]Zhang X, Liu N, Ma D, et al.Receptor for activated C kinase 1 (RACK1) promotes the progression of OSCC via the AKT/mTOR pathway[J]. Int J Oncol,2016,49(2):539-548.
[8]Hu F, Tao Z, Wang M, et al. RACK1 promoted the growth and migration of the cancer cells in the progression of esophageal squamous cell carcinoma[J]. Tumour Biol, 2013, 34(6):3893-3899.
[9]Campagne C, Julé S, Alleaume C, et al. Canine melanoma diagnosis: RACK1 as a potential biological marker[J]. Vet Pathol,2013,50(6):1083-1090.
[10]Choi YY, Lee SY, Lee WK, et al. RACK1 is a candidate gene associated with the prognosis of patients with early stage non-small cell lung cancer[J]. Oncotarget,2015,6(6):4451-4466.
[11]Deng YZ, Yao F, Li JJ, et al. RACK1 suppresses gastric tumorigenesis by stabilizing the β-catenin destruction complex[J]. Gastroenterology,2012,142(4):812-823.
[12]Chen L, Min L, Wang X, et al. Loss of RACK1 promotes metastasis of gastric cancer by inducing a miR-302c/IL8 signaling loop[J]. Cancer Res,2015,75(18):3832-3841.
[13]Yong-Zheng X, WanLi M, Ji-Ming M, et al.Receptor for activated protein kinase C 1 suppresses gastric tumor progression through nuclear factor-κB pathway[J]. Indian J Cancer,2015,52 (Suppl 3):E172-175.
[14]Wang YZh, Guo L, Liu YM, et al.Expressions and clinical significance of Rack1and β-catenin in gastric carcinoma tissue[J]. Chinese Journal of Biochemical and Pharmaceutics, 2016,36(3): 30-33. (in Chinese)
王一曌,郭琳,刘乙蒙,等.Rack1与β-catenin在胃癌组织中的表达与临床意义[J].中国生化药物杂志,2016,36(3):30-33.
[15]Kim HY, Cho Y, Kang H, et al.Targeting the WEE1 kinase as a molecular targeted therapy for gastric cancer[J].Oncotarget, 2016,7(31):49903-49916
[16]Huang YY, Pei XL, Liu Y, et al. Expression of tumor stem cell markers in the tumor sphere from esophageal squamous cells carcinoma Eca109[J]. Acta Anatomic Sinica, 2014, 45(3): 350-353. (in Chinese)
黄燕燕,裴学莲,刘洋,等.多种肿瘤干细胞标志物在食管鳞癌Eca109细胞球细胞中的表达[J]. 解剖学报, 2014, 45(3): 350-353.
|